Related Experiment Video
Updated: Jul 19, 2026
05:44
Formation of Dispersible Taohong Siwu Tablets
Published on: February 3, 2023
Current perspectives in dissolution testing of conventional and novel dosage forms
Shirzad Azarmi1, Wilson Roa, Raimar Löbenberg
1Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada T6J 2L7.
International Journal of Pharmaceutics
|November 7, 2006
Summary
This review covers United States Pharmacopeia (USP) and alternative dissolution testing methods for pharmaceutical dosage forms. It offers insights into dissolution study designs and media selection for drug development.
Area of Science:
- Pharmaceutical Sciences
- Drug Delivery and Formulation
Background:
- Dissolution testing is critical for evaluating pharmaceutical product performance.
- Conventional and novel dosage forms require tailored dissolution assessment strategies.
Purpose of the Study:
- To review established United States Pharmacopeia (USP) dissolution testing methods.
- To explore non-pharmacopeial and alternative dissolution testing approaches for various dosage forms.
- To provide guidance on dissolution study design and appropriate dissolution media selection.
Main Methods:
- Comprehensive literature review of USP and non-pharmacopeial dissolution testing methodologies.
- Analysis of dissolution testing methods applied to conventional and novel pharmaceutical dosage forms.
- Evaluation of alternative dissolution study designs and dissolution media.
Main Results:
- Detailed overview of USP dissolution methods for different pharmaceutical dosage forms.
- Presentation of various alternative dissolution testing techniques employed in research and development.
- Discussion on factors influencing the choice of dissolution media and study design.
Conclusions:
- Understanding diverse dissolution testing methods is essential for pharmaceutical development.
- Alternative approaches offer flexibility and can provide deeper insights into drug release.
- Optimized study design and media selection are crucial for predicting in vivo performance.
Related Concept Videos
01:13In Vitro Drug Dissolution: Compendial Testing Models I
Compendial dissolution methods are standardized procedures defined by pharmacopeias to evaluate the rate at which a drug dissolves in a specific medium. These methods ensure batch-to-batch consistency, enable quality control, and support the prediction of drug bioavailability. They are critical for both immediate and modified-release drug products.The apparatuses used for dissolution testing differ in their design and mechanical function, but all aim to simulate the physiological environment of...
01:17In Vitro Drug Dissolution: Alternative Methods
Alternative drug dissolution methods include the rotating bottle, intrinsic dissolution test, peristalsis, and the Franz diffusion cell method. The rotating bottle method involves meticulously rotating tightly capped controlled-release beads in a temperature-controlled bath. Periodic decanting of samples allows for residue assay, followed by refilling with fresh medium and testing at various pH levels to emulate the gastrointestinal tract conditions.In contrast, the intrinsic dissolution test...
01:09In Vitro Drug Dissolution: Compendial Testing Models II
Various dissolution methods are utilized to assess a drug’s dissolution rate, including the flow-through cell, paddle-over-disk, cylinder, and reciprocating disk methods.The flow-through cell apparatus (USP (United States Pharmacopeia) method 4) comprises a reservoir for the dissolution medium and a pump that propels the medium through the cell containing the test sample. This method is crucial for assessing modified-release dosage forms with minimally soluble active ingredients, maintaining...
01:14Drug Dissolution: Requirements and Profile Comparison
The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...
01:10In Vitro Drug Release Testing: Overview, Development and Validation
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
01:23Factors Affecting Dissolution: Particle Size and Effective Surface Area
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are employed to...